Label Changes for:
Kerledex (betaxolol hydrochloride and chlorthalidone)
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011
- Both digitalis glycosides and betablockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia.